Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of a Single-shot Wound Infiltration With Bupivacaine/Adrenalin During Cesarean Section in Reducing Postoperative Pain. A Randomized Prospective Controlled Trial

NCT03395912 is registered in ClinicalTrials.gov with HaEmek Medical Center, Israel as lead sponsor.

NCT NCT03395912
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03395912 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of a Single-shot Wound Infiltration With Bupivacaine/Adrenalin During Cesarean Section in Reducing Postoperative Pain. A Randomized Prospective Controlled Trial
Lead sponsor
HaEmek Medical Center, Israel
Phase
Not applicable
Overall status
Completed
Start date
January 25, 2018
Completion date
June 30, 2021
Enrollment
288 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cesarean section